Compare QSI & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QSI | BHK |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 655.1M |
| IPO Year | 2020 | N/A |
| Metric | QSI | BHK |
|---|---|---|
| Price | $0.74 | $8.76 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 222.4K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | ★ 28.17 | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $2,436,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $618.07 | N/A |
| P/E Ratio | ★ N/A | $8.63 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $8.69 |
| 52 Week High | $3.10 | $10.12 |
| Indicator | QSI | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 41.86 | 34.96 |
| Support Level | $0.70 | N/A |
| Resistance Level | $1.04 | $9.08 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 5.10 | 3.80 |
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.